Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children’s Oncology Group protocol AAML0531
Andrew P. Voigt, Lisa Eidenschink Brodersen, Todd A. Alonzo, et al.
Haematologica (2017) Vol. 102, Iss. 12, pp. 2058-2068
Open Access | Times Cited: 25

Showing 25 citing articles:

Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in PediatricKMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531
Jessica A. Pollard, Erin Guest, Todd A. Alonzo, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 28, pp. 3149-3160
Open Access | Times Cited: 77
CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group
Adam J. Lamble, Lisa Eidenschink Brodersen, Todd A. Alonzo, et al.
Journal of Clinical Oncology (2021) Vol. 40, Iss. 3, pp. 252-261
Open Access | Times Cited: 35
Unraveling genotype–phenotype associations and predictive modeling of outcome in acute myeloid leukemia
Artuur Couckuyt, Sofie Van Gassen, Annelies Emmaneel, et al.
Cytometry Part B Clinical Cytometry (2025)
Open Access
Computational analysis of flow cytometry data in hematological malignancies: future clinical practice?
Carolien Duetz, Costa Bachas, Theresia M. Westers, et al.
Current Opinion in Oncology (2019) Vol. 32, Iss. 2, pp. 162-169
Closed Access | Times Cited: 42
Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes
Carolien Duetz, Theresia M. Westers, Arjan A. van de Loosdrecht
Pathobiology (2018) Vol. 86, Iss. 1, pp. 14-23
Open Access | Times Cited: 34
Opportunities for immunotherapy in childhood acute myeloid leukemia
Adam J. Lamble, Sarah K. Tasian
Blood Advances (2019) Vol. 3, Iss. 22, pp. 3750-3758
Open Access | Times Cited: 31
Morphologic remission status is limited compared to ΔN flow cytometry: a Children’s Oncology Group AAML0531 report
Lisa Eidenschink Brodersen, Robert B. Gerbing, María Laura Pardo, et al.
Blood Advances (2020) Vol. 4, Iss. 20, pp. 5050-5061
Open Access | Times Cited: 24
Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia
Flávia Melo Cunha de Pinho Pessoa, Caio Bezerra Machado, Igor Valentim Barreto, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1098-1098
Open Access | Times Cited: 8
Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Laura Pardo, Andrew P. Voigt, Todd A. Alonzo, et al.
Cytometry Part B Clinical Cytometry (2019) Vol. 98, Iss. 1, pp. 52-56
Open Access | Times Cited: 21
Utility of CD36 as a novel addition to the immunophenotypic signature of RAM‐phenotype acute myeloid leukemia and study of its clinicopathological characteristics
Devasis Panda, Gaurav Chatterjee, Rohan Sardana, et al.
Cytometry Part B Clinical Cytometry (2020) Vol. 100, Iss. 2, pp. 206-217
Open Access | Times Cited: 20
The impact of Down syndrome‐specific non‐malignant hematopoietic regeneration in the bone marrow on the detection of leukemic measurable residual disease
Fan‐Chi Hsu, Chad A. Hudson, Elisabeth R. Wilson, et al.
Cytometry Part B Clinical Cytometry (2023) Vol. 104, Iss. 4, pp. 311-318
Closed Access | Times Cited: 6
Contemporary Challenges in Clinical Flow Cytometry: Small Samples, Big Data, Little Time
Jonathan R. Brestoff, John L. Frater
The Journal of Applied Laboratory Medicine (2021) Vol. 7, Iss. 4, pp. 931-944
Closed Access | Times Cited: 15
CD56, HLA‐DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3‐GLIS2 fusion transcript
Andrea Zangrando, Francesca Cavagnero, Pamela Scarparo, et al.
Cytometry Part A (2021) Vol. 99, Iss. 8, pp. 844-850
Open Access | Times Cited: 11
Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity
Smeeta Gajendra, Shilpa Anupurba, Ritu Gupta, et al.
International Journal of Laboratory Hematology (2023) Vol. 45, Iss. 4, pp. 541-552
Closed Access | Times Cited: 4
Measuring response to therapy in AML: Difference from normal flow cytometry vs RQ-PCR
Michael R. Loken, Chad A. Hudson
Methods in cell biology (2024), pp. 233-247
Closed Access | Times Cited: 1
Acute myeloid leukemia
Mekhala Rao, Girish Kamat, Deepak Goni, et al.
BLDE University Journal of Health Sciences (2022) Vol. 7, Iss. 1, pp. 115-120
Open Access | Times Cited: 7
On Its Way to Primetime: Artificial Intelligence in Flow Cytometry Diagnostics
Stefan W. Krause
Cytometry Part A (2020) Vol. 97, Iss. 10, pp. 990-993
Open Access | Times Cited: 6
PDX models of relapsed pediatric AML preserve global gene expression patterns and reveal therapeutic targets
Mark Wunderlich, Jing Chen, Christina Sexton, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Monitoring AML Response Using “Difference from Normal” Flow Cytometry
Michael R. Loken, Lisa Eidenschink Brodersen, Denise A. Wells
Springer eBooks (2018), pp. 101-137
Closed Access | Times Cited: 3
Measurable Residual Disease Assessment in Pediatric AML
Martina Pigazzi, Claudia Tregnago, Chad A. Hudson, et al.
Pediatric oncology (2024), pp. 79-101
Closed Access
Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56‐positive acute leukemias
Hanan Hamdan, Yen‐Chun Liu, Sa A. Wang, et al.
eJHaem (2024) Vol. 6, Iss. 1
Open Access
Opportunities for immunotherapy in childhood acute myeloid leukemia
Adam J. Lamble, Sarah K. Tasian
Hematology (2019) Vol. 2019, Iss. 1, pp. 218-225
Open Access | Times Cited: 2
Combination of FLT3-ITD Allelic Ratio, NPM1 Mutation, and Immunophenotypic Markers to Modulate Outcome Prediction in Patients with Normal Karyotype Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation
Gina Jiang, José‐Mario Capo‐Chichi, Aijun Liu, et al.
Biology of Blood and Marrow Transplantation (2020) Vol. 26, Iss. 11, pp. 1995-2000
Open Access | Times Cited: 2
Immunophenotypic characterization of pediatric acute myeloid leukemia with inv(16)(p13.1q22)/t(16;16)(p13.1;q22)/CBFb-MYH11
Ekaterina Mikhailova, S. A. Kashpor, Elena Zerkalenkova, et al.
Pediatric Hematology/Oncology and Immunopathology (2021) Vol. 20, Iss. 1, pp. 46-53
Open Access | Times Cited: 1
AML1-ETO-positive acute myeloid leukemia presents different phenotype in pediatric and adult patients
Guopan Yu, Zhao Yin, Ying Yang, et al.
Authorea (Authorea) (2020)
Open Access
Page 1

Scroll to top